New Delhi: The Serum Institute of India’s CEO Adar Poonawalla in a tweet on Wednesday said that he is going to reduce the Covishield price to the State Governments ₹ 300 instead of ₹ 400.

Poonawalla in his tweet wrote that “As a philanthropic gesture on behalf of Serum Institute of India, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives”. From May 1, as vaccinations open to all adults, states and private entities can buy doses directly from manufacturers under the Centre’s liberalized policy to tackle the explosion of Covid – 19 cases.
State Governments and private hospitals can order up to 50 per cent of Serum’s Covishield and Bharat Biotech’s Covaxin to inoculate the younger population, while the Centre will buy the other half to continue vaccinating those above 45 free of cost. Serum said it would continue to provide vaccines to the centre at ₹ 150 a shot. While Serum announced a price of ₹ 400 rupees for states and ₹ 600 for private hospitals, Bharat Biotech set the prices at ₹ 600 and ₹ 1,200 a dose.

The subsidized rate of ₹ 150 per dose to the Government was only for a “limited” period of time, said Serum CEO Adar Poonawalla. “We’re supplying in India at approximately ₹ 150-160. The average price is around $20 (Rs 1,500), because of the request of Modi Government, we are providing at subsidized rates. It is not that we’re not making profits, but we are not making super profits, which is key to re-investing,” he said.